Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 17 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//MICROBIOLOGY//JOURNAL OF BACTERIOLOGY | 725599 |
| 222 | 3 | AQUEOUS TWO PHASE SYSTEMS//CORYNEBACTERIUM GLUTAMICUM//BIOCHEMISTRY & MOLECULAR BIOLOGY | 49487 |
| 2051 | 2 | LESCH NYHAN SYNDROME//LESCH NYHAN DISEASE//TIAZOFURIN | 5700 |
| 11284 | 1 | TIAZOFURIN//IMPDH//BENZAMIDE RIBOSIDE | 1021 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TIAZOFURIN | authKW | 1377511 | 6% | 76% | 59 |
| 2 | IMPDH | authKW | 663598 | 4% | 50% | 43 |
| 3 | BENZAMIDE RIBOSIDE | authKW | 536813 | 2% | 87% | 20 |
| 4 | IMP DEHYDROGENASE | authKW | 424528 | 3% | 49% | 28 |
| 5 | IMPDH INHIBITORS | authKW | 405473 | 2% | 77% | 17 |
| 6 | INOSINE MONOPHOSPHATE DEHYDROGENASE | authKW | 267910 | 2% | 35% | 25 |
| 7 | INOSINE 5 MONOPHOSPHATE DEHYDROGENASE | authKW | 172839 | 1% | 40% | 14 |
| 8 | TIAZOFURIN ANALOGUES | authKW | 154335 | 0% | 100% | 5 |
| 9 | IMP DEHYDROGENASE INHIBITOR | authKW | 128611 | 0% | 83% | 5 |
| 10 | GMP REDUCTASE | authKW | 98773 | 0% | 80% | 4 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Chemistry, Medicinal | 2614 | 15% | 0% | 158 |
| 2 | Biochemistry & Molecular Biology | 1847 | 37% | 0% | 377 |
| 3 | Oncology | 943 | 17% | 0% | 178 |
| 4 | Chemistry, Organic | 618 | 12% | 0% | 127 |
| 5 | Pharmacology & Pharmacy | 476 | 15% | 0% | 151 |
| 6 | Biophysics | 198 | 6% | 0% | 62 |
| 7 | Medicine, Research & Experimental | 48 | 4% | 0% | 39 |
| 8 | Cell Biology | 33 | 5% | 0% | 52 |
| 9 | Hematology | 32 | 3% | 0% | 26 |
| 10 | Genetics & Heredity | 32 | 4% | 0% | 39 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MED EXPTL ONCOL | 39683 | 0% | 43% | 3 |
| 2 | 237 HIRANOMACHI CHUO KU | 30867 | 0% | 100% | 1 |
| 3 | AFMBUMR 6098 | 30867 | 0% | 100% | 1 |
| 4 | CANC TREATMENT CLIN PHARMACOL BRANCH | 30867 | 0% | 100% | 1 |
| 5 | CANC TREATMENTPEDIAT BRANCHBLDG 10 | 30867 | 0% | 100% | 1 |
| 6 | CHEM VRILLY RECH | 30867 | 0% | 100% | 1 |
| 7 | CLIN NUESTRA SENORA CONCEPT | 30867 | 0% | 100% | 1 |
| 8 | CNRSERT 5ENSCM | 30867 | 0% | 100% | 1 |
| 9 | EA267 | 30867 | 0% | 100% | 1 |
| 10 | ERT 5 | 30867 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ADVANCES IN ENZYME REGULATION | 59805 | 3% | 6% | 34 |
| 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 12717 | 4% | 1% | 44 |
| 3 | NUCLEOSIDES & NUCLEOTIDES | 10414 | 1% | 2% | 15 |
| 4 | CURRENT MEDICINAL CHEMISTRY | 3573 | 2% | 1% | 23 |
| 5 | JOURNAL OF MEDICINAL CHEMISTRY | 3198 | 5% | 0% | 48 |
| 6 | CANCER BIOCHEMISTRY BIOPHYSICS | 3016 | 1% | 2% | 6 |
| 7 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1858 | 4% | 0% | 40 |
| 8 | CANCER RESEARCH | 1669 | 5% | 0% | 47 |
| 9 | CANCER COMMUNICATIONS | 1207 | 0% | 2% | 2 |
| 10 | BIOCHEMICAL PHARMACOLOGY | 1166 | 3% | 0% | 27 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |